News
“This study supports dose finding for research and psychedelic-assisted therapy.” In a previous study, several researchers from the same group also found no significant differences in the psychedelic ...
Conclusion: The present study provides evidence of a protracted analgesic effect of LSD at a dose that is low enough to avoid a psychedelic experience.
A single dose of psilocybin, the active compound in “magic mushrooms,” given to mice prompted a long-lasting increase in the connections between neurons.
Cancer patients given a single dose of psilocybin, the psychedelic drug in magic mushrooms, had improved anxiety and depression for years.
Compass Pathways has made two 250-gram batches of psilocybin, the active ingredient in magic mushrooms. Compass is testing the drug in Europe and North America and has funding from Peter Thiel to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results